Brief communications: changes in inflammatory biomarkers and lipid profiles after switching to long-acting cabotegravir plus rilpivirine - Adachi, Eisuke; Saito, Makoto; Otani, Amato; Koga, Michiko; Yotsuyanagi, Hiroshi (AIDS research and therapy, 2024)
Keywords: Acquired immune deficiency syndrome; AIDS; Analysis; Analysis and chemistry; Anti-HIV Agents - therapeutic use; Anti-Retroviral Agents - therapeutic use; Antiretroviral drugs; Antiviral agents; Biological markers; Biomarkers; Blood; Blood cholesterol; C-reactive protein; Cabotegravir plus rilpivirine; CD4 antigen; CD8 antigen; Cholesterol; Cholesterol - therapeutic use; Clinical medicine; Clinical trials; Density; Dosage and administration; Drug dosages; Health aspects; High density lipoprotein; HIV; HIV Infections - drug therapy; Human immunodeficiency virus; Humans; Inflammation; Inflammatory biomarker; Inflammatory diseases; Lipid profile; Lipids; Long-acting drug; Low density lipoproteins; Measurement; Raltegravir; Rilpivirine; Rilpivirine - therapeutic use; Switching; Tenofovir; Variance analysis; Japan; Cabotegravir plus rilpivirine; Lipid profile; Long-acting drug; HIV; Inflammatory biomarker